Ligand profile
SZK
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_31828 — UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2, 6-diaminopimelate ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
SZK- PDB
7b6l- UniProt (similar protein)
P22188- Target protein
- KP13_31828
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 43.0
- −1 ≤ LogP ≤ 5 3.26
- MW ≤ 500 Da 241.3
- LogP ≤ 5 3.26
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 43.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCn1c2ccccc2nc1NCc3ccco3CCn1c2ccccc2nc1NCc3ccco3
InChI=1S/C14H15N3O/c1-2-17-13-8-4-3-7-12(13)16-14(17)15-10-11-6-5-9-18-11/h3-9H,2,10H2,1H3,(H,15,16)InChI=1S/C14H15N3O/c1-2-17-13-8-4-3-7-12(13)16-14(17)15-10-11-6-5-9-18-11/h3-9H,2,10H2,1H3,(H,15,16)
XVKUMXLSEKBYCF-UHFFFAOYSA-NXVKUMXLSEKBYCF-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF08245
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand SZK →
- PDB RCSB structure 7b6l →
- UniProt UniProt P22188 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “SZK”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_31828.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 9
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).